Home » Topics » BioWorld Science

BioWorld Science
RSS

InnoCare Pharma patents indoleamine 2,3-dioxygenase 1 inhibitors

Aug. 16, 2019

New sialyltransferase inhibitors synthesized at Radboud Universiteit Nijmegen

Aug. 16, 2019

Triple kinase inhibitor IBL-302 shows promising activity in preclinical models of neuroblastoma

Aug. 16, 2019

Fast skeletal muscle troponin activators can counter skeletal muscle fatigue

Aug. 16, 2019

Adropin is correlated with erectile dysfunction in coronary artery disease patients

Aug. 16, 2019

IL-13Rlalpha2 as a therapeutic target in inflammatory bowel disease

Aug. 16, 2019

TNFR2 is yang to TNFR1's yin

Aug. 16, 2019

FDA clears Heat Biologics' IND for study of HS-130 plus HS-110

Aug. 14, 2019

Too much oxygen may be issue in Leigh syndrome

Aug. 14, 2019

European Commission approves ibrutinib for expanded use in two indications

Aug. 14, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...